Company
United StatesPublic company, NYSE: MDTMedtronic (NYSE: MDT), Hopkinton, MA – FDA Inspections
Inspection records and compliance data for Medtronic in Hopkinton, Massachusetts. 2 FDA inspections on record, last inspected January 25, 2012. Publicly traded as NYSE: MDT.
Company Profile
This profile covers Medtronic based in Hopkinton, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected March 24, 2010. Last inspected January 25, 2012.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 25, 2012 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 764458 |
| March 24, 2010 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 653482 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Mount Auburn Hospital Blood Bank
CCRM Boston, PLLC
Brigham and Women's Hospital Blood Donor / Transfusion Service
Southcoast Hospitals Group, Inc. / St. Luke's Hospital Blood Bank
Raymond T. Chung, M.D.
SYNLOGIC
Baystate Franklin Medical Center, BB
Charlton Memorial Southcoast Hospitals Group Campus
Southcoast Health Tobey Hospital
Zepto Metrix Corporation
Company Information
Name
Medtronic
Stock ticker
MDT
Exchange
NYSE
Share price
$105.03
Market cap
$134.3B
Price as of
November 6, 2026
FEI Number
3004580324
Address
Spinal And Biologics Division, 239 South St Fl 2nd, Hopkinton, Massachusetts 01748, United States
Country
United States
ID: 5bb3a09f-6764-4e37-8374-f3617d19514c